samsca is a pregnancy category c therapy. there are no adequate and well-controlled studies of samsca use in pregnant women. samsca use should be avoided during pregnancy unless the potential benefit justifies the potential risk to the fetus. it is not known whether samsca is excreted into human milk. samsca is excreted into the milk of lactating rats. because many drugs are excreted into human milk and because of the potential for serious adverse reactions in nursing infants from samsca a decision should be made to discontinue nursing or avoid samsca taking into consideration the importance of samsca to the mother. to lessen your risk of osmotic demyelination syndrome (ods) while taking samsca: treatment should be started and re-started only in the hospital where the sodium levels in your blood can be monitored closely. do not take samsca if you can't tell if you are thirsty. to prevent dehydration while taking samsca drink when you are thirsty and have water available to drink at all times unless the healthcare provider tells you otherwise. do not stop and restart samsca on your own. if you stop samsca for any reason talk to your healthcare provider right away. other important information: call your healthcare provider immediately if you experience any side effects that bother you while taking samsca. read the medication guide to understand the risks and benefits of samsca.
can samsca be used in patients who are pregnant or breastfeeding?